Skip to main content
Log in

Corticosteroid-induced osteoporosis: Effects of a treatment with slow-release sodium fluoride

  • Short Report
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lukert B, Raisz L. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352–64.

    Google Scholar 

  2. Pak C, Sakhaee K, Zerwekh J, et al. Safe and effective treatment of osteoporosis with intermittent slow-release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 1989;68:150–9.

    Google Scholar 

  3. Mamelle N, Meunier PJ, Dusan R, et al. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988;2:361–5.

    Google Scholar 

  4. Bayley T, Muller C, Harrison J, et al. The long-term treatment of steroid osteoporosis with fluoride. J Bone Miner Res 1990;5(Suppl 1):S157–61.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greenwald, M., Brandli, D., Spector, S. et al. Corticosteroid-induced osteoporosis: Effects of a treatment with slow-release sodium fluoride. Osteoporosis Int 2, 303–304 (1992). https://doi.org/10.1007/BF01623187

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623187

Keywords

Navigation